Naziv |
Akcije |
Dobrenić, Margareta ; Kralik, Marko ; Divošević, Sunčana
Hrvatski konsenzus o dijagnostici i liječenju limfoma - zaključci Radne skupine za slikovnu dijagnostiku // Bilten Krohema, 15 (2023), 1; 3-7 |
|
Premužić, Vedran ; Bašić-Kinda, Sandra ; Radman, Ivo ; Dujmović, Dino ; Ilić, Ivana ; Živković, Neno ; Maleta, Lucija ; Kralik, Marko ; Dobrenić, Margareta ; Galunić-Bilić, Lea et al.
Glomerular filtration rate is an independent prognostic factor in patients with B-large cell lymphoma // Medicine, 102 (2023), 20; 33675, 5. doi: 10.1097/MD.0000000000033675 |
|
Hude Dragičević, Ida ; Bašić-Kinda, Sandra ; Dujmović, Dino ; Radman, Ivo ; Dreta, Barbara ; Dotlić, Sandra ; Galunić- Bilić, Lea ; Dobrenić, Margareta ; Kralik, Marko ; Rončević, Pavle et al.
Reduced steroid exposure is safe and does not reduce disease control among Hodgkin lymphoma patients treated with escalated BEACOPP (eBEACOPP) // The 12th International Symposium on Hodgkin Lymphoma Abstract Book, HemaSPhere 6(S5). 2022. str. 8-9 |
|
Bašić-Kinda, Sandra ; Radman, Ivo ; Dujmović, Dino ; Ilić, Ivana ; Kralik, Marko ; Dobrenić, Margareta ; Galunić-Bilić, Lea ; Rončević, Pavle ; Vodanović, Marijo ; Sertić, Zrinka et al.
R-CHOEP14 in younger high-risk patients with large B cell lymphoma: an effective front-line regimen with cardiac toxicity: a real-life, single-center experience // Annals of hematology, 100 (2021), 6; 1517-1524. doi: 10.1007/s00277-020-04353-3 |
|
Basic-Kinda, Sandra ; Dujmovic, Dino ; Radman, Ivo ; Moric Peric, Martina ; Hude, Ida ; Durakovic, Nadira ; Vodanovic, Marijo ; Dobrenic, Margareta ; Kralik, Marko ; Galunic-Bilic, Lea et al.
eBEACOPP for front-line treatment of patients with classical Hodgkin lymphoma (cHL) in the real world setting. 2018. str. 26-26 |
|
Božina, Nada ; Bilić, Ivan ; Pleština, Stjepko ; Vrbanec, Damir ; Kralik, Marko ; Ganoci, Lana
DPYD polymorphisms and fluoropyrimidine toxicity- a single institution case control study // Abstract Book of the 15th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology / - : IATDMCT, 2017. 2017 |
|
Hrabak Paar, Maja ; Kralik, Marko
Case 244 // Radiology, 283 (2017), 1; 300-302. doi: 10.1148/radiol.2017151157 |
|
Hrabak-Paar, Maja ; Kralik, Marko
Case 244 : Systemic Amyloidosis—A Complication of Waldenström Macroglobulinemia // Radiology, 284 (2017), 2; 597-602. doi: 10.1148/radiol.2017151156 |
|
Aurer, Igor ; Nemet, Damir ; Mitrović, Zdravko ; Dujmović, Dino ; Bašić-Kinda, Sandra ; Radman, Ivo ; Sertić, Dubravka ; Šantek, Fedor ; Kralik, Marko ; Dotlić, Snježana et al.
High-dose ifosfamide and mitoxantrone (HDIM) in patients with relapsed or refractory Hodgkin's lymphoma // Annals of hematology, 95 (2016), 7; 1129-1136. doi: 10.1007/s00277-016-2676-0 |
|
Aurer, Igor ; Basic-Kinda, Sandra ; Dujmovic, Dino ; Radman, Ivo ; Dreta, Barbara ; Dotlic, Snjezana ; Galunic-Bilic, Lea ; Dobrenic, Margareta ; Kralik, Marko ; Roncevic, Pavle
The switch from ABVD to eBEACOPP as front-line therapy for high-risk patients stage III-IV Hodgkin lymphoma (CHL) patients results in an inversion of event-free survival (EFS) of prognostic groups. 2016. str. 24-24 |
|